Industry News - The Ministry of Commerce and nine other departments released policies to expand service consumption, including a series of promotional activities and optimizing operational hours for popular cultural and tourist venues [2][3] - The Ministry of Industry and Information Technology issued guidelines for the digital transformation of key industries, providing scenario maps for 14 sectors including steel, petrochemicals, and new energy vehicles [2][3] - The National Medical Products Administration approved the first medical device standard for brain-computer interface technology, set to be implemented on January 1, 2026 [2] - The People's Bank of China stated that the CIPS cross-border payment system has become a crucial support for the internationalization of the Renminbi [2] Company News - Tianpu Co. announced that the acquisition funds of 9.65 billion yuan from Zhonghao Xinying have been received [3][13] - Haowen Automotive announced a significant contract worth approximately 24.77 billion yuan for ADAS perception systems and radar systems [7] - Luxiao Technology plans to launch a family AI service robot, aiming to sell at least 1 million units in the US and European markets by 2026-2028 [8] - Tianqi Lithium stated that its pilot project for producing 50 tons of lithium sulfide has commenced [9] - Hangke Technology announced a share transfer price of 28.61 yuan per share, at a 20% discount to the closing price [10] - Brother Technology expects a year-on-year net profit increase of 207%-253% for the first three quarters of 2025 [13] Investment Opportunities - The humanoid robot industry is anticipated to enter a sales growth phase, with expectations for significant advancements and market readiness by 2026 [15] - Nvidia is requesting suppliers to develop new micro-channel liquid cooling plate (MLCP) technology due to increased power consumption of its new AI platforms, indicating a shift in cooling technology requirements [16]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688366 证券简称：昊海生科 公告编号：2025-042 上海昊海生物科技股份有限公司 行政处罚最终结果将以中国证监会对蒋伟先生最终出具的《行政处罚决定书》结论为准。公司将持续关 注上述事项的进展情况，并按照有关法律法规的规定和要求，及时履行信息披露义务，敬请广大投资者 注意投资风险。 特此公告。 上海昊海生物科技股份有限公司董事会 2025年9月17日 收到《行政处罚事先告知书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 上海昊海生物科技股份有限公司（以下简称"公司"）控股股东、实际控制人之一蒋伟先生于2025年5月 收到中国证券监督管理委员会（以下简称"中国证监会"）出具的《立案告知书》（编号：证监立案字 0382025016 号）。因其涉嫌内幕交易，根据《中华人民共和国证券法》《中华人民共和国行政处罚 法》等法律法规，中国证监会决定对其立案。具体内容详见公司于2025年5月8日披露的《上海昊海生物 科技股份有限公司关于控股股东、实际控制人之一 ...

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen stock markets announced significant developments, including financing arrangements, asset sales, and strategic partnerships, which may present investment opportunities and risks for investors [4][5][6][8][9][10]. Financing and Borrowing - Vanke A announced that its largest shareholder, Shenzhen Metro Group, will provide a loan of up to 2.064 billion yuan to repay bond principal and interest, with a loan term of no more than three years and a floating interest rate based on the LPR minus 66 basis points [4]. - Jianfeng Group obtained a loan commitment of up to 36 million yuan from China Merchants Bank for stock repurchase, with a loan term of no more than 36 months at an interest rate of 1.8% [11]. Asset Sales and Acquisitions - Angli Education plans to sell 100% of Kensington Park School Limited for 80,000 pounds (approximately 760,100 yuan) to alleviate financial pressure [5]. - Guang'an Aizhong intends to acquire 90% of Qitai Hengtai at a price of 0 yuan, with plans for further investment in renewable energy projects [12][13]. - Suzhou Planning aims to acquire 80% of Kunshan Development Zone Architectural Design Institute for 831,720 yuan [18]. Regulatory and Compliance Issues - Haohai Biotechnology's controlling shareholder received an administrative penalty notice from the CSRC for suspected insider trading, although it is stated that this will not significantly impact the company's operations [7]. - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate financial disclosures in its 2015 annual report [8]. Performance and Forecasts - Brothers Technology expects a net profit of 100 million to 115 million yuan for the first three quarters of 2025, representing a year-on-year increase of 207.32% to 253.42%, driven by rising prices of certain vitamin products and improved production efficiency [21]. Strategic Partnerships and Contracts - Jiuzhou Yiqu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [22]. - Luxiao Technology's subsidiary signed a strategic cooperation agreement to develop AI service robots for the US and European markets, aiming to sell at least 1 million units by 2026-2028 [23]. - China Shipbuilding Technology signed a green methanol sales contract worth approximately 40 million USD per year, with potential increases based on customer demand [24]. Stock Transactions and Shareholder Actions - Several companies, including Maidi Technology and Xin Hua Co., announced plans for shareholders to reduce their stakes, with reductions ranging from 1.7% to 3% of total shares [29][30][31][34][35].

每经编辑｜黄胜 9月16日，昊海生科（688366.SH）公告称，公司控股股东、实际控制人之一蒋伟于2025年5月收到中国证监会出具的《立案告知书》。因其涉嫌内幕交易， 中国证监会决定对其立案。近日，公司收到蒋伟通知，获悉其收到中国证监会出具的《行政处罚事先告知书》。该《行政处罚事先告知书》所涉主体为蒋伟 个人，涉及的事项与公司无关。蒋伟不参与公司日常经营管理，该事项不会对公司日常经营、业务及财务造成重大影响。 图片来源：视觉中国-VCG211322973159 | | | | 前 10 名股东持股情况(不含通过转融通出借股份) | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名称 | 股东性质 | 持股数量 | 持股比 例(%) | 持有有 限售条 | 包含转融通 借出股份的 | 质押、标记或冻结 情况 | | | | | | | 件股份 | 限售股份数 | 股份状 | | | | | | | 数量 | 喜 | 不 | 数量 | | 将伟 | 境内自然人 | 66,528,000 | 28.53 | 0 | 0 | 元 | 0 ...

据昊海生科5月8日披露的公告显示，蒋伟因涉嫌内幕交易被证监会立案。 北京商报讯（记者 丁宁）9月16日晚间，昊海生科（688366）发布公告称，近日，公司收到控股股东、 实际控制人之一蒋伟通知，获悉其收到证监会出具的《行政处罚事先告知书》。 昊海生科表示，该《行政处罚事先告知书》所涉主体为蒋伟个人，涉及的事项与公司无关。蒋伟不参与 公司日常经营管理，该事项不会对公司日常经营、业务及财务造成重大影响。 ...

Major Events - Angli Education plans to sell 100% equity of Kensington Park School Limited for £80,000 (approximately 760,100 RMB) to Hong Kong KS Education Group Limited to alleviate operational difficulties and reduce financial impact [1] Regulatory Actions - Haohai Biological's controlling shareholder, Jiang Wei, received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) for suspected insider trading, which does not impact the company's daily operations or finances [2] - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate information disclosure in its 2015 annual report, involving former executives who are now subject to administrative measures [3] Corporate Actions - Yaoshi Technology announced that the last day for conversion of Yaoshi convertible bonds is September 17, after which unconverted bonds will be forcibly redeemed at 100.62 RMB per bond, potentially leading to investment losses for investors [4] - Kanghui Pharmaceutical intends to change its stock abbreviation from "Kanghui Pharmaceutical" to "Kanghui Co., Ltd." [5] Strategic Partnerships - Jiuzhou Yitu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [6] - Luxiao Technology's subsidiary signed a strategic cooperation agreement to jointly develop AI service robots for the U.S. and European markets, aiming to sell at least 1 million units between 2026 and 2028 [6] - China Shipbuilding Technology signed a green methanol sales contract worth approximately $40 million per year, with potential increases based on customer demand, starting supply in 2028 [6] - Haon Automotive received a product designation notice for ADAS perception systems and radar systems, estimating total revenue of approximately 2.477 billion RMB over a 5-year project lifecycle, with mass production expected to start in April 2026 [6] Shareholding Changes - Medi Technology's shareholder, Weng Kang, plans to reduce his stake by up to 1.7% of the company's total shares, while another shareholder, Wu Di, intends to reduce his holdings by up to 0.0047% [7] - Xinhua Co., Ltd.'s director, Fang Junwei, plans to reduce his holdings by up to 75,200 shares, representing no more than 0.039% of the company's total shares [7]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Shanghai Haohai Biological Technology Co., Ltd.* 上海昊海生物科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 茲載列本公司在上海證券交易所網站刊登之《上海昊海生物科技股份有限公司關 於公司控股股東、實際控制人之一因非本公司事項收到<行政處罰事先告知書>的 公告》，僅供參考。 承董事會命 上海昊海生物科技股份有限公司 主席 侯永泰 中國上海，2025年9月16日 於本公告日期，本公司之執行董事為侯永泰博士、吳劍英先生、陳奕奕女士及 唐敏捷先生；本公司之非執行董事為游捷女士、黃明先生及魏長征先生；及本公 司之獨立非執行董事為沈紅波先生、姜志宏先生、蘇治先生及楊玉社先生。 * 僅供識別 证券代码：688366 证券简称：昊海生科 公告编号：2025-042 （股份代號：6826） 海外監管公告 本公告乃由上海昊海生物科技股份有限公司（「本公司」）根 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海昊海生物科技股份有限公司（於中華人民共和國註冊成立的股份有限公司） FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06826 | 說明 | H 股 | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | | | 佔有關事件前的現有 ...

智通财经APP讯，昊海生物科技(06826)发布公告，于2025年9月16日斥资27.68万港元回购1万股。 该信 息由智通财经网提供 ...

行政处罚最终结果将以中国证监会对蒋伟先生最终出具的《行政处罚决定 书》结论为准。公司将持续关注上述事项的进展情况，并按照有关法律法规的规 定和要求，及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 上海昊海生物科技股份有限公司董事会 2025 年 9 月 17 日 证券代码：688366 证券简称：昊海生科 公告编号：2025-042 上海昊海生物科技股份有限公司 关于公司控股股东、实际控制人之一因非本公司事项 收到《行政处罚事先告知书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海昊海生物科技股份有限公司（以下简称"公司"）控股股东、实际控制 人之一蒋伟先生于 2025 年 5 月收到中国证券监督管理委员会（以下简称"中国 证监会"）出具的《立案告知书》（编号：证监立案字 0382025016 号）。因其涉 嫌内幕交易，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等 法律法规，中国证监会决定对其立案。具体内容详见公司于 2025 年 5 月 8 日披 露的《上海昊海生物科技股份有限 ...